Hi-Tech Pharmacal Reports Q4 Sales of $58.5M vs. $66.3M Est., Adjusted EPS of $0.50 vs. $0.63 Est.

Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK ) today reported results for the fourth quarter and year ended April 30, 2013. Net sales of $58.5 million for the fourth quarter compared to $61.3 million for the same prior year period GAAP loss of $4.6 million or $0.34 per diluted share